Literature DB >> 21976942

Analysis of the effects of medial rectus muscle resection for recurrent exotropia.

Young-Woo Suh1, Il Hun Seo, Yoonae A Cho, Seung-Hyun Kim.   

Abstract

PURPOSE: The purpose of this paper is to investigate how much correction is obtained per millimeter of medial rectus (MR) resection for recurrent exotropia after bilateral lateral rectus (BLR) recession, and to determine the difference in the effects between unilateral and bilateral resection, and the influence of previous lateral rectus (LR) recession on the effects of MR resection.
METHODS: A total of 59 patients who had undergone MR resection after BLR recession were included in this study. The unilateral group consisted of 38 patients and bilateral group, 21 patients. Thirty patients in the unilateral group were divided into two groups: patients who had undergone previous LR recession of 7 mm or greater (21 patients) and less than 7 mm (9 patients). Main outcome measures were average deviation corrected per millimeter of MR resection at 1 month postoperative.
RESULTS: The average effect of MR resection was 4.2 prism diopters (PD, 2.0 to 6.7 PD)/mm. The average effect in the unilateral group was 4.2 PD/mm and 4.1 PD/mm in the bilateral group. There was no significant difference between groups (P = 0.60). The average effect in the recession 7 mm or greater group was 4.0 PD/mm, and the average effect in the recession less than 7 mm group was 4.2 PD/mm (P = 0.698).
CONCLUSIONS: The effect of MR resection per millimeter was variable. The laterality and previous amount of LR recession did not influence the effect of MR resection. These variable outcomes dictate that caution be exercised when MR resection is performed for recurrent exotropia.

Entities:  

Keywords:  Exodeviation; Oculomotor muscles; Strabismus

Mesh:

Year:  2011        PMID: 21976942      PMCID: PMC3178769          DOI: 10.3341/kjo.2011.25.5.341

Source DB:  PubMed          Journal:  Korean J Ophthalmol        ISSN: 1011-8942


  7 in total

1.  Ten years follow-up of surgery for intermittent exotropia.

Authors:  P Zibrandtsen; E Rindziunski; E Gregersen
Journal:  Acta Ophthalmol (Copenh)       Date:  1986-08

2.  Recession of the lateral recti. Early and late postoperative alignments.

Authors:  E L Raab; M M Parks
Journal:  Arch Ophthalmol       Date:  1969-08

3.  Role of the equator in the early overcorrection of intermittent exotropia.

Authors:  Yoonae A Cho; Seung-Hyun Kim
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2009 Jan-Feb       Impact factor: 1.402

4.  Effects of surgery on the dominant eye in exodeviations.

Authors:  G Lennerstrand
Journal:  Acta Ophthalmol (Copenh)       Date:  1986-08

5.  Unilateral rectus resection in the treatment of undercorrected or recurrent strabismus.

Authors:  S E Olitsky; C Kelly; H Lee; L B Nelson
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2001 Nov-Dec       Impact factor: 1.402

6.  Long-term results of unilateral lateral rectus recession in intermittent exotropia.

Authors:  Subhash Dadeya
Journal:  J Pediatr Ophthalmol Strabismus       Date:  2003 Sep-Oct       Impact factor: 1.402

7.  The effect of unilateral medial rectus muscle resection in patients with recurrent exotropia.

Authors:  Sun Hwa Chae; Bo Young Chun; Jung Yoon Kwon
Journal:  Korean J Ophthalmol       Date:  2008-09
  7 in total
  3 in total

Review 1.  Surgical treatment for residual or recurrent strabismus.

Authors:  Tao Wang; Li-Hua Wang
Journal:  Int J Ophthalmol       Date:  2014-12-18       Impact factor: 1.779

2.  Surgical outcome of medial rectus resection in recurrent exotropia: a novel surgical formula.

Authors:  Abbie Sheung-Wan Luk; Jason Cheuk-Sing Yam; Henry Hing-Wai Lau; Wilson Wai-Kuen Yip; Alvin Lerrmann Young
Journal:  J Ophthalmol       Date:  2015-03-17       Impact factor: 1.909

3.  Reoperation in Horizontal Strabismus and its Related Risk Factors.

Authors:  Zhale Rajavi; Mohammad Gozin; Hamideh Sabbaghi; Narges Behradfar; Bahareh Kheiri; Mohmmad Faghihi
Journal:  Med Hypothesis Discov Innov Ophthalmol       Date:  2018
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.